Medullary Thyroid Cancer Documents

File Size
2020 Thyroid Immune profiling of MTC 06-2019.pdf 2.93 MB
ACS MEN2 Consortium December 2012 Update 01-2013.pdf 168.7 KB
ATA Initial Diagnosis and Therapy Updated 07-2013.pdf 241.22 KB
ATA Updated MTC Guidelines 07-2013.pdf 330.7 KB
ATA ultrasound updates for patterns in MTC 05-2015.pdf 107.22 KB
ATF4 protein targets RET 02-2017.pdf 125.72 KB
Acid alkaline food chart.pdf 121.98 KB
Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers 11-2009.pdf 108.8 KB
After surgery - What is your Category of risk 02-2015.pdf 102.02 KB
American Cancer Society MEN Constortium Update 10-2013.pdf 128.52 KB
App H Sporadic MTC Registry Study Advertisement 11-2018.pdf 172.21 KB
Axitinib-Phase II Trial 06-2014.pdf 134.24 KB
Biopsy problems lead to wrong surgery 01-2014.pdf 101.91 KB
C-Cells can secrete ACTH and create Cushings 01-2013.pdf 108.34 KB
CA 19-9 MTC Marker 09-2013.pdf 96.09 KB
CEA Trial - NIH Phase II 09-2013.pdf 100.6 KB
Cabo (Cometriq) and weight loss 03-2015.pdf 106.33 KB
Cabo - RET and RAS mutations 08-2013.pdf 181.13 KB
Cabometyx is Cometriq or Cabo 04-2016.pdf 134.98 KB
Calcitonin Assays Needs Antibody Blockers for Accurate Testing 02-2012.pdf 126.92 KB
Calcitonin lab handling - Mayo 02-2015.pdf 124.65 KB
Calcium Receptors for MTC imaging 11-2013.pdf 96.53 KB
Cancer of the Thyroid - SEER Stat Fact Sheets 08-2012.pdf 77.75 KB
Caprelsa - Vandentinib Guidelines and Manufacturers Information 03-2012.pdf 93.9 KB
Caprelsa Dosage and Side Effects 07-2014.pdf 104.32 KB
Caprelsa Medication Guide 03-2014.pdf 69.47 KB
Caprelsa and Body Mass Toxic Effects 06-2013.pdf 97.14 KB
Cases of Severe Skin Reactions- Sutent(Sunitinib) 09-2013.pdf 99.61 KB
Cdk5 Protein in C-cells as well as brain 10-2013.pdf 98.02 KB
Chart of RET mutations and exons.pdf 180.09 KB
Chemo related Diarrhea 10-2014.pdf 114.19 KB
Cometriq Side Effects 07-2014.pdf 149.77 KB
Cometriq better for RET mutations 12-2013.pdf 124.77 KB
Cometriq-Atezolizumab (Immuno Combo) Trial 03-2017.pdf 185.12 KB
Common lab values 03-2017.pdf 93.2 KB
Complete Response in Murine Tumor Model 02-2002.pdf 261.45 KB
Considering a Chemo 10-2014.pdf 195.52 KB
Cushings Reversal vs Causing Cushings 08-2013.pdf 100.34 KB
Cushings video - coordinating care 03-2015.pdf 94.64 KB
DNA Genomes 09-2013.pdf 96.82 KB
Digestive Manifestations of Parathyroid Disease 07-2014.pdf 154.25 KB
Disability helpful hints.pdf 111.95 KB
Dr Gil Cote Laboratory Assays 12-2013.pdf 4.97 MB
Dr Jan Mueller-Brand DOTA Therapy 05-2013.pdf 473.92 KB
Dr Jan Mueller-Brand practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumors 02-2013.pdf 419.57 KB
Drug Companies and Drugs researching MTC 06-2015.pdf 103.44 KB
Everolimus and Resistance 03-2015.pdf 99.11 KB
Experts Talk WHY you need a Multidisciplinary Team 08-2013.pdf 96.58 KB
Experts on MTC 10-2014.pdf 129.32 KB
Extent of surgery and survival in MTC 11-2013.pdf 149.93 KB
FDA on how to measure patient benefit in drug approvals 06-2017.pdf 175.32 KB
Free Tumor Testing 06-2020.pdf 96.66 KB
Future Potential Therapies for MTC 09-2014.pdf 98.1 KB
GENR Study Advertisement.pdf 154.24 KB
Gallium 68 imaging 11-2013.pdf 96.06 KB
Genetic Testing in MTC 08-2013.pdf 92.88 KB
German medullary thyroid carcinoma-multiple endocrine neoplasia registry 01-1998.pdf 66.09 KB
Germline and Somatic Mutations Explained.pdf 147.09 KB
HIV Drug shows activity in MTC 09-2013.pdf 100.55 KB
HIV Protease inhibits MTC cell growth 12-2013.pdf 138.99 KB
Hand and Foot Study 01-2014.pdf 99.75 KB
History of CEA 01-2016.pdf 141.59 KB
How fast does MTC grow 12-2013.pdf 100.59 KB
How to select the right TKI 10-2014.pdf 96.56 KB
Hypercaloric recipes while on EBR.pdf 84.21 KB
Hypoparathyroidism Forecast.pdf 4.28 MB
Hypoparathyroidism and the effects on bones kidneys brain 01-2015.pdf 155.63 KB
Hypothyroid-T4 and T3 conversion roles 11-2014.pdf 102.17 KB
IPSOS Thyca recuitement flyer 05-2016.pdf 98.63 KB
Imaging with MTC 07-2013.pdf 97.46 KB
Immunesurveillance by dendritic cells-potential implications for immunotherapy 2006.pdf 533.56 KB
Importance of multidisciplinary medical team 11-2014.pdf 96.44 KB
Importance of the FIRST Operation 09-2012.pdf 116.66 KB
Insulin Medullary Registry UBC 06-2015.pdf 1.39 MB
Interleukin-2 & Lanreotide study Italy 10-2013.pdf 95.55 KB
International Endocrine Society links 09-2015.pdf 135.2 KB
Intro and overview of MTC 07-2013.pdf 96.63 KB
Keytruda - Things to give to your doctor at home for consideration 06-2017.pdf 197.73 KB
Kinase Inhibiters for MTC 10-2014.pdf 292.28 KB
Know your TKI target 04-2016.pdf 93.29 KB
LU177 Therapy 01-2014.pdf 1.57 MB
Lenvatinib RET inhibitor 02-2014.pdf 101.72 KB
Lodging and travel with airline info.pdf 248.48 KB
MEN MEN2a and MEN2b and spontaneous mutations 08-2016.pdf 168.11 KB
MEN2A and Cushings 01-2013.pdf 115.36 KB
MTC Adverse events with therapy 06-2012.pdf 114.33 KB
MTC Centers of Excellence List 01-2012.pdf 204.33 KB
MTC Drug Costs.pdf 96.89 KB
MTC FAQ 01-2012.pdf 250.29 KB
MTC FAQs for newbies and others 03-2017.pdf 188.1 KB
MTC Survival statistic research 11-2015.pdf 116.73 KB
MTC Video Links 07-2013.pdf 95.3 KB
MTC and RET 02-2012.pdf 89.92 KB
MTC and Staging 08-2013.pdf 93.81 KB
MTC guidelines 02-2012.pdf 91.57 KB
MTC reverse with dichloroacetate 03-2014.pdf 135.75 KB
MTC videos from NCCN 01-2014.pdf 95.77 KB
MTC xenograft study quote 10-2015.pdf 116.13 KB
Management of MTC and MEN2 in Childhood 08-2011.pdf 489.14 KB
Mattuci 2014 - Pheochomocytoma and paraganglioma- diagnosis, genetics, management and treatment 2014.pdf 1.62 MB
MediCare payment for CEA testing for MTC 04-2009.pdf 75.98 KB
Medullary Bone Met study MDA 2016 Stats 04-2016.pdf 208.53 KB
Medullary Octreotide Therapy 09-2013.pdf 240.29 KB
Multiple Endocrine Neoplasia - MEN2 Guide 08-2009.pdf 823.32 KB
NCCN Thyroid Cancer Webinar Dr Tuttle 2013.pdf 1 MB
NORD Hypoparathyroidism 08-2014.pdf 162.71 KB
NORD Use Your Voice Pheoniz 06-2015.pdf 121.13 KB
Northern California Workshop 06-2014.pdf 74.21 KB
Nutrition drink comparison.pdf 201.49 KB
Obesity not linked to Medullary 09-2015.pdf 155.32 KB
One Size does not Fit All 05-2013.pdf 161.19 KB
PD-1 Blocker 06-2012.pdf 2.04 MB
Paraneoplastic Syndromes NETs 2010.pdf 386.16 KB
Parathyroid and Adrenal Glands 09-2014.pdf 97.54 KB
Phase II trial for pre-targeted radioimmunotherapy 06-2012.pdf 972.98 KB
Pheos and MEN Study 09-2013.pdf 98.87 KB
Ponatinib 06-2013.pdf 771.85 KB
Ponatinib 09-2013.pdf 91.36 KB
Ponatinib warnings 07-2014.pdf 410.96 KB
Post-TT-Physical-Therapy-Guide.pdf 321.3 KB
Post-op monitoring and when to consider treatment 05-2017.pdf 92.95 KB
Predicting Cushings in Medullary 01-2013.pdf 117.52 KB
Pretargeted radioimmunotherapy in MTC 2009.pdf 479.66 KB
Primary Treatment Video from MTC Experts 05-2017.pdf 162.88 KB
Procalcitonin vs Calcitonin 09-2012.pdf 264.96 KB
Programmed Death Ligand 1 (PD-L1) 10-2013.pdf 96.75 KB
RET Status importance 08-2013.pdf 95.19 KB
RET TEST before TKI use Caprelsa 04-2016.pdf 166.5 KB
RET Testing BEFORE TKI use with Cabo 06-2015.pdf 141.37 KB
RET testing and mutation points 01-2014.pdf 98.88 KB
RET804 AMEND Mutliple Mutation Points 12-2010.pdf 232.53 KB
RFA for MTC 2006.pdf 409.42 KB
Radiation - This may help 08-2013.pdf 98.54 KB
Revised-ATA-MTC-Guidelines-2017.pdf 922.1 KB
Risk management for SDHA SDHB AND SDHC gene mutations 06-2013.pdf 1.4 MB
SERUM Calcium Correction for Serum albumin Medical Calculator.pdf 159.71 KB
Saxenda-Boxed warning on MTC 12-2014.pdf 103.42 KB
Shoulder Pain after surgery and nerve damage 11-2014.pdf 122.98 KB
Stop the Clot 10-2012.pdf 278.43 KB
Surgery for advanced disease and Cushings 09-2013.pdf 95.46 KB
Surivival Improvement for MTC Patients with Radioimmunotherapy 04-2006.pdf 365.36 KB
T3 three times daily 01-2015.pdf 96.8 KB
TKI Study Adverse Events and Compliance 09-2015.pdf 233.53 KB
TKI drug interactions 08-2013.pdf 2.32 MB
TKI side effects to monitor 03-2014.pdf 119.94 KB
TKI use must not be taken lightly 05-2015.pdf 343.48 KB
TKI use study 10-2015.pdf 210.93 KB
TSH Questions 04-2016.pdf 98.13 KB
Tackling cancer myths 03-2017.pdf 93.75 KB
Testing Advanced MTC 08-2013.pdf 94.18 KB
Testing Sporadic or Familial.pdf 131.35 KB
The HypoPARA-Post 2014.pdf 5.86 MB
ThyCa Dr Gil Cote MTC biology 2012.pdf 5.65 MB
Thyca 2013 Dr Ball 09-2013.pdf 107.35 KB
Thyca 2013 Dr Hu 09-2013.pdf 114.1 KB
Thyca 2013 Dr Sherman 09-2013.pdf 108.45 KB
Thyca Conference - Ross Cagan - 2013.pdf 145.32 KB
Thyca Conference 2013 - ACS Research - Dr. Chen 2013.pdf 120.27 KB
Thyca Conference 2013 - Medullary Thyroid Carcinoma Novel Chemotherapies - Dr. Mimi Hu 2013.pdf 141.45 KB
Thyca Dr Ross Cagan Presentation 09-2013.pdf 234.96 KB
Thyca conference 2012 Note 1 10-2012.pdf 114.18 KB
Thyca thyroid infographic.pdf 870.27 KB
ThyroSeq - New FNA biopsy Tool 10-2013.pdf 130.48 KB
Treating Progressive MTC-Cabo 09-2012.pdf 125.74 KB
Treating Progressive MTC-Caprelsa 09-2012.pdf 105.61 KB
Tumor Suppressor Role of Notch-1 11-2014.pdf 299.17 KB
Tumor-targeting micelles conjugated with the somatostatin analog KE108 10-2014.pdf 148.25 KB
US Conference on Rare Diseases and Orphan Products 10-2013.pdf 3.52 MB
USE YOUR VOICE Patient Worksheet - San Francisco.pdf 119.33 KB
USE YOUR VOICE Patient Worksheet Charlotte.pdf 123.51 KB
USE YOUR VOICE Patient Worksheet Chicago.pdf 149.76 KB
Update on Structural Thyroid Disease Webinar 01-2015.pdf 101.79 KB
Variantsin Stem Cell Division 08-2014.pdf 579.66 KB
Video link - Dr Dadu discusses the efficacy of CASAD in reducing MTC-related diarrhea 11-2014.pdf 103.37 KB
Video link on Treating Advancing MTC 11-2014.pdf 96.49 KB
Vit D hydroxy Study and Cancer outcomes 03-2017.pdf 149.83 KB
Watch and wait and why 11-2016.pdf 173.29 KB
What imaging is most accurate 07-2012.pdf 92.12 KB
When to use the TKIs Caprelsa and Comtriq 10-2014.pdf 98.63 KB
Yale MTC Thyroid Health Study - web based consent 06-2013.pdf 261.46 KB
Zoledronic Acid for bone Mets 06-2014.pdf 120.78 KB